Newsquawk Logo

Eli Lilly's (LLY) CEO says that the number of people engaging with the Lilly direct has increased to over 1mln patients in 2025

Eli Lilly's announcement about its engagement with over 1 million patients suggests strong demand for its offerings, which reflects positively on its future growth trajectory.

Newsquawk StaffPublished On the live feed at — 6 more headlines followed before this page went public
Newsquawk headlinesUTC

Barclays (BARC LN) and NatWest (NWG LN) to submit formal offer over GBP 2bln for wealth manager Evelyn, via Sky News

Eli Lilly (LLY) exec says that price is expected to drag on growth in the low to mid teens range in 2026

Eli Lilly's (LLY) CEO says that the number of people engaging with the Lilly direct has increased to over 1mln patients in 2025

Turkish President Erdogan says they oppose US military intervention against Iran

Mexico's President, on oil shipments, says Cuba has an open credit line and they make payments on it

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Try the platform free
Free. No signup, no card.
  • Eli Lilly (LLY) exec says that price is expected to drag on growth in the low to mid teens range in 2026.
  • Company also plans to launch its obesity pill outside the US in 2027.
Context

However, the CEO's mention of pricing pressures expected to moderate growth in the low to mid-teens for 2026 indicates potential headwinds that investors should be aware of. Additionally, plans to launch the obesity pill internationally could create new revenue streams, but the timing and execution will be key.

Related headlines

The whole workspace, free to try.

Try it free
Newsquawk Logo

© 2026 Newsquawk. All rights reserved.